Showing results (641-650 of 5,340) with videos related to

Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|July 30, 2024
A review of cutaneous apocrine carcinoma: epidemiology, diagnosis, prognosis, and treatment optionsSeiji Tsuruta, Dai Ogata, Kenjiro Namikawa, et al.
Japanese Journal of Clinical Oncology|August 19, 2024
The effect of aroma lymphatic tressage on taxane-induced lower-extremity edema in breast cancer patientsYang Sun Ha, Ju Won Kim, Ji Yoon Lee, et al.
Japanese Journal of Clinical Oncology|June 28, 2024
Sarcopenic obesity predicts short- and long-term outcomes after neoadjuvant chemotherapy and surgery for gastric cancerChunning Duan, Mingru Wu, Xia Wen, et al.
Japanese Journal of Clinical Oncology|June 1, 1991
Fiberoptic ductoscopy of the breast: a new diagnostic procedure for nipple dischargeA Okazaki, M Okazaki, K Asaishi, et al.
Japanese Journal of Clinical Oncology|June 29, 2006
Glu346Lys polymorphism in the methyl-CpG binding domain 4 gene and the risk of primary lung cancerMoo Chul Shin, Su Jeong Lee, Jin Eun Choi, et al.
Japanese Journal of Clinical Oncology|March 15, 2006
Triplet chemotherapy for malignant pericardial mesothelioma: a case reportRiichiroh Maruyama, Maki Sakai, Tomomi Nakamura, et al.
Japanese Journal of Clinical Oncology|June 10, 2006
Modified and bilateral retroperitoneal lymph node dissection for testicular cancer: peri- and postoperative complications and therapeutic outcomeToshiaki Tanaka, Hiroshi Kitamura, Yasuharu Kunishima, et al.
Japanese Journal of Clinical Oncology|June 20, 2006
[F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomasKen-ichi Watanabe, Hiroaki Nomori, Takashi Ohtsuka, et al.
Japanese Journal of Clinical Oncology|June 20, 2006
Cigarette smoking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among JapaneseKeitaro Tanaka, Ichiro Tsuji, Kenji Wakai, et al.
Japanese Journal of Clinical Oncology|December 1, 1991
Alternating chemotherapy with cyclophosphamide/adriamycin/vincristine (CAV) and cisplatin/etoposide (PVP) against small cell lung cancer. Eastern Shikoku Lung Cancer Chemotherapy GroupH Bando, Y Takishita, T Ogura, et al.
Pageof 534